Author

Bipinesh Sansar

h-index 5 View on Semantic Scholar

We have 3 of 48 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

From Crisis to Clarity: The Essential Role of Genetic Counseling and Emerging Risk-Reducing Strategies in BRCA1 -Associated Breast Cancer – A Case Report

Abstract Women with BRCA1 pathogenic variants face high lifetime risks of breast and ovarian cancer, requiring complex risk-reducing decisions. We report a 35-year-old woman with node-negative triple-negative breast cancer who achieved a pathologic complete response after neoadjuvant chemotherapy and breast-conserving...

Archi Rungta, Anjana Anoop, Srushti Uthale et al. · Indian Journal of Medical an... · 0 citations

Review Open access Jan 2026

Carbapenem Resistance in India: A Systematic Review of Epidemiology, Diagnostic Strategies, and Therapeutic Approaches

Carapenem resistance in India remains alarmingly high, primarily driven by NDM and OXA‐type carbapenemases, and optimised diagnostics, improved access to effective antimicrobials, robust antimicrobial stewardship, and national surveillance are critical to mitigate its growing clinical and public health impact.

A. Kapoor, Anuj Gupta, Bipinesh Sansar et al. · BioMed Research Internationa... · 0 citations

Review Aug 2026

KRAS-Targeted Therapies in NSCLC: Resistance, Combination Strategies, and Emerging Clinical Paradigms

KRAS-mutant NSCLC is transitioning from historically untargetable disease to a therapeutically actionable subset, and future progress hinges on resistance-directed combinations, biomarker-guided personalization, expansion to non-G12C mutants, and evaluation in earlier disease settings.

A. Kapoor, Bipinesh Sansar, Anuj Gupta et al. · Medical Oncology · 0 citations